Dr. Divya M

Consultant

10 Years of Experience

Hematologist

MBBS, MD, DM

English

Consultation Fee ₹ 800

WhatsApp Us

Dr Divya M is a highly skilled hemato oncologist with 10 years of experience.
Her areas of expertise include clinical hematology, pediatric hematology, and oncology.
She is proficient in benign and malignant hematology and Bone Marrow Transplant (BMT).
She completed her MBBS from Chengalpattu Govt. Medical College University, Chengalpattu District in 2014.
Dr. Divya M pursued an MD in Pathology from Lady Hardinge Medical College, New Delhi, in 2018.
She obtained her DM in Clinical Hematology from Madras Medical College, Chennai, in 2023.
She is a member of the Delhi Medical Council and the Tamil Nadu Medical Council.

Get a Treatment Plan Within 1 Hour

Name*

Mobile Number*

Query

MBBS, Chengalpattu Govt. Medical College University, Chengalpattu District, 2014
MD in Pathology, Lady Hardinge Medical College, New Delhi, 2018
DM in Clinical Hematology, Madras Medical College, Chennai, 2023

Junior Resident, Melmaruvathur Adhiparasakthi Medical College Hospital, Melmaruvathur
Duty Medical Officer, Casualty Medical Officer-Atomic Energy Central Govt. Hospital, Kalpakkam
Senior Resident, St. John’s Medical College, Bangalore

Second Prize, Medal Exam, Orthopedics, 2013
First Prize, Quiz competition, Midterm Hemato-oncology Update and Masterclass, 2022
Third Prize, Quiz competition, Hemato-Oncology Conference, 2023

She has numerous publications. One of the papers published is:

Divya M, Margaret C, Karthikeyan A, Ranjan A, Kumar K, Yellugoti V, Hari V. Observational Study on Treatment and Prognosis Of COVID-19 Related Thrombocytopenia. Indian Journal of Hematology and Blood Transfusion. 2022:S70-.
Agarwal K, Garg J, Mahajan G, Yadav PS, Manohar D.An Unusual Presentation of Metanephric Adenofibroma: A Rare Case Report.J Clin of Diagn Res.2017; 11(10):ED01-ED03. https://www.doi.org/10.7860/JCDR/2017/30881/1069
Hari V, Karthikeyan A, Rajendran A, Divya M, Yellugoti V. A study on clinic demographic profile and diagnostic parameters in myeloma. Inj J Acad Med Pharm. 2023; 5 (2): 1075-1078
‘Study of complications during treatment of acute lymphoblastic leukemia in children, adolescents, and young adults – experience from tertiary care centers, South India.’ – Oral paper in joint conference in Indian Society of Medical and Pediatric Oncology (ISMPO) and Indian Society of Oncology (ISO) 28-30 October 2022.